{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:19:17Z","timestamp":1789712357016,"version":"4.0.1"},"reference-count":93,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T00:00:00Z","timestamp":1711065600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","contactlensjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contact Lens and Anterior Eye"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.clae.2024.102154","type":"journal-article","created":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T13:36:09Z","timestamp":1711200969000},"page":"102154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Lipid-based eye drop formulations for the management of evaporative dry eyes"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0374-2504","authenticated-orcid":false,"given":"Furqan A.","family":"Maulvi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ditixa T.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parthasarathi","family":"Kalaiselvan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srikanth","family":"Dumpati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Kuppusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin","family":"Masoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh O.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.P.","family":"Willcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clae.2024.102154_b0005","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/ICL.0000000000000643","article-title":"A new perspective on dry eye classification: proposal by the Asia dry eye society","volume":"46","author":"Tsubota","year":"2020","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.clae.2024.102154_b0010","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/704946","article-title":"A comprehensive review on dry eye disease: diagnosis, medical management, recent developments, and future challenges","volume":"2015","author":"Phadatare","year":"2015","journal-title":"Advances in Pharmaceutics"},{"issue":"2","key":"10.1016\/j.clae.2024.102154_b0015","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","article-title":"The definition and classification of dry eye disease","volume":"5","author":"Lemp","year":"2007","journal-title":"Ocul Surf"},{"issue":"23","key":"10.1016\/j.clae.2024.102154_b0020","doi-asserted-by":"crossref","first-page":"9271","DOI":"10.3390\/ijms21239271","article-title":"Defining dry eye from a clinical perspective","volume":"21","author":"Tsubota","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.clae.2024.102154_b0025","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1089\/jop.2017.0052","article-title":"Relevance of lipid-based products in the management of dry eye disease","volume":"33","author":"Garrigue","year":"2017","journal-title":"J Ocul Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.clae.2024.102154_b0030","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1542-0124(12)70085-X","article-title":"Management and therapy of dry eye disease: report of the Management and therapy Subcommittee of the International dry eye WorkShop (2007)","volume":"5","author":"Pflugfelder","year":"2007","journal-title":"Ocular Surface"},{"issue":"3","key":"10.1016\/j.clae.2024.102154_b0035","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jtos.2016.04.005","article-title":"Understanding symptoms and quality of life in patients with dry eye syndrome","volume":"14","author":"Barabino","year":"2016","journal-title":"Ocul Surf"},{"key":"10.1016\/j.clae.2024.102154_b0040","unstructured":"Chang AY, Purt B. Biochemistry, tear film. 2021."},{"key":"10.1016\/j.clae.2024.102154_b0045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.exer.2017.03.013","article-title":"Structure-function relationship of tear film lipid layer: a contemporary perspective","volume":"163","author":"Georgiev","year":"2017","journal-title":"Exp Eye Res"},{"issue":"3 Suppl","key":"10.1016\/j.clae.2024.102154_b0050","first-page":"S79","article-title":"Dry eye disease: pathophysiology, classification, and diagnosis","volume":"14","author":"Perry","year":"2008","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.clae.2024.102154_b0055","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.preteyeres.2014.11.001","article-title":"Dynamics and function of the tear film in relation to the blink cycle","volume":"45","author":"Braun","year":"2015","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"10.1016\/j.clae.2024.102154_b0060","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/NHH.0000000000000652","article-title":"Dry eye disease: prevalence, assessment, and management","volume":"36","author":"Rouen","year":"2018","journal-title":"Home Healthcare Now"},{"issue":"3","key":"10.1016\/j.clae.2024.102154_b0065","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jtos.2017.04.001","article-title":"TFOS DEWS II sex, gender, and hormones report","volume":"15","author":"Sullivan","year":"2017","journal-title":"Ocul Surf"},{"issue":"5","key":"10.1016\/j.clae.2024.102154_b0070","doi-asserted-by":"crossref","first-page":"e359","DOI":"10.1111\/j.1755-3768.2012.02413.x","article-title":"The diagnostic significance of fourier-domain optical coherence tomography in sj\u00f6gren syndrome, aqueous tear deficiency and lipid tear deficiency patients","volume":"90","author":"Qiu","year":"2012","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"10.1016\/j.clae.2024.102154_b0075","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jtos.2017.03.006","article-title":"TFOS DEWS II tear film report","volume":"15","author":"Willcox","year":"2017","journal-title":"Ocul Surf"},{"issue":"8","key":"10.1016\/j.clae.2024.102154_b0080","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1167\/iovs.14-16313","article-title":"The effects of increasing ocular surface stimulation on blinking and tear secretion","volume":"56","author":"Wu","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clae.2024.102154_b0085","doi-asserted-by":"crossref","unstructured":"Craig JP, Nelson JD, Azar DT, Belmonte C, Bron AJ, Chauhan SK, et al. The TFOS dry eye workshop II: executive summary. 2017.","DOI":"10.12968\/opti.2017.10.6820"},{"issue":"4","key":"10.1016\/j.clae.2024.102154_b0090","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.survophthal.2007.04.009","article-title":"The correlation between the tear film lipid layer and dry eye disease","volume":"52","author":"Foulks","year":"2007","journal-title":"Surv Ophthalmol"},{"issue":"5","key":"10.1016\/j.clae.2024.102154_b0095","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/ICL.0b013e3181ef0d37","article-title":"Meibomian gland dysfunction: the past, present, and future","volume":"36","author":"Foulks","year":"2010","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.clae.2024.102154_b0100","doi-asserted-by":"crossref","unstructured":"King-Smith PE, Braun RJ. Author response: More to stable tears than thickness of the lipid layer. Investigative Ophthalmology & Visual Science 2015;56(3):1602-.","DOI":"10.1167\/iovs.15-16607"},{"issue":"6","key":"10.1016\/j.clae.2024.102154_b0105","first-page":"14","article-title":"The therapeutic role of lipids\u2014Managing Ocular Surface disease","volume":"9","author":"Lemp","year":"2005","journal-title":"Refractive Eyecare for Ophthalmologists"},{"key":"10.1016\/j.clae.2024.102154_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121105","article-title":"Recent advances in ophthalmic preparations: Ocular barriers, dosage forms and routes of administration","volume":"608","author":"Maulvi","year":"2021","journal-title":"Int J Pharm"},{"key":"10.1016\/j.clae.2024.102154_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100842","article-title":"Advances in the diagnosis and treatment of dry eye","volume":"78","author":"Kojima","year":"2020","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.clae.2024.102154_b0120","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/B978-0-12-820007-0.00028-3","article-title":"Ophthalmic preparations","author":"Maulvi","year":"2021","journal-title":"Remington Elsevier"},{"key":"10.1016\/j.clae.2024.102154_b0125","series-title":"Ophthalmic and otic drug administration: novel approaches and challenges","first-page":"335","author":"Desai","year":"2019"},{"issue":"3 Suppl","key":"10.1016\/j.clae.2024.102154_b0130","first-page":"S88","article-title":"Management of dry eye disease","volume":"14","author":"Lemp","year":"2008","journal-title":"Am J Manag Care"},{"issue":"3 Suppl","key":"10.1016\/j.clae.2024.102154_b0135","first-page":"S102","article-title":"Prevalence, burden, and pharmacoeconomics of dry eye disease","volume":"14","author":"Pflugfelder","year":"2008","journal-title":"Am J Manag Care"},{"issue":"1","key":"10.1016\/j.clae.2024.102154_b0140","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00006324-199701000-00014","article-title":"Importance of the lipid layer in human tear film stability and evaporation","volume":"74","author":"Craig","year":"1997","journal-title":"Optom Vis Sci"},{"issue":"7","key":"10.1016\/j.clae.2024.102154_b0145","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/ICO.0b013e318191b870","article-title":"The relationship between dry eye symptoms and lipid layer thickness","volume":"28","author":"Blackie","year":"2009","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.clae.2024.102154_b0150","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3109\/02713683.2011.631721","article-title":"A single LipiFlow\u00ae thermal pulsation system treatment improves meibomian gland function and reduces dry eye symptoms for 9 months","volume":"37","author":"Greiner","year":"2012","journal-title":"Curr Eye Res"},{"issue":"6","key":"10.1016\/j.clae.2024.102154_b0155","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/ICL.0000000000000228","article-title":"Clinical trial of thermal pulsation (LipiFlow) in meibomian gland dysfunction with preteatment meibography","volume":"42","author":"Zhao","year":"2016","journal-title":"Eye Contact Lens"},{"issue":"2","key":"10.1016\/j.clae.2024.102154_b0160","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.ICL.0000060998.20142.8D","article-title":"Increase in tear film lipid layer thickness following treatment with warm compresses in patients with meibomian gland dysfunction","volume":"29","author":"Olson","year":"2003","journal-title":"Eye Contact Lens"},{"issue":"6","key":"10.1016\/j.clae.2024.102154_b0165","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.1475-1313.1995.9500071k.x","article-title":"Tear lipid layer structure and stability following expression of the meibomian glands","volume":"15","author":"Craig","year":"1995","journal-title":"Ophthalmic Physiol Opt"},{"issue":"6","key":"10.1016\/j.clae.2024.102154_b0170","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/sj.eye.6701611","article-title":"Tear film lipid layer thickness and ocular comfort after meibomian therapy via latent heat with a novel device in normal subjects","volume":"19","author":"Mitra","year":"2005","journal-title":"Eye"},{"key":"10.1016\/j.clae.2024.102154_b0175","first-page":"293","article-title":"Increase in tear film lipid layer thickness following treatment of meibomian gland dysfunction. lacrimal gland, Tear film, and dry eye syndromes","author":"Korb","year":"1994","journal-title":"Basic Science and Clinical Relevance Springer"},{"key":"10.1016\/j.clae.2024.102154_b0180","doi-asserted-by":"crossref","unstructured":"Vicario-de-la-Torre M, Ben\u00edtez-del-Castillo JM, Vico E, Guzm\u00e1n M, de-Las-Heras B, Herrero-Vanrell R, et al. Design and characterization of an ocular topical liposomal preparation to replenish the lipids of the tear film. Investigative ophthalmology & visual science 2014;55(12):7839-47.","DOI":"10.1167\/iovs.14-14700"},{"issue":"9","key":"10.1016\/j.clae.2024.102154_b0185","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.18240\/ijo.2020.09.05","article-title":"Crosslinked hyaluronic acid with liposomes and crocin for management symptoms of dry eye disease caused by moderate meibomian gland dysfunction","volume":"13","author":"S\u00e1nchez-Gonz\u00e1lez","year":"2020","journal-title":"Int J Ophthalmol"},{"issue":"6","key":"10.1016\/j.clae.2024.102154_b0190","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1089\/jop.2020.0011","article-title":"Cationic emulsion-based artificial tears as a mimic of functional healthy tear film for restoration of ocular surface homeostasis in dry eye disease","volume":"36","author":"Daull","year":"2020","journal-title":"J Ocul Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.clae.2024.102154_b0195","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1080\/02713683.2022.2039205","article-title":"Management strategies for evaporative dry eye disease and future perspective","volume":"47","author":"Rolando","year":"2022","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.clae.2024.102154_b0200","article-title":"Functional ibuprofen-loaded cationic nanoemulsion: development and optimization for dry eye disease treatment","volume":"576","author":"Dukovski","year":"2020","journal-title":"Int J Pharm"},{"issue":"5","key":"10.1016\/j.clae.2024.102154_b0205","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.3390\/ijms23052434","article-title":"Artificial tears: biological role of their ingredients in the management of dry eye disease","volume":"23","author":"Labetoulle","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.clae.2024.102154_b0210","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1097\/OPX.0b013e31826f32e0","article-title":"Lipid-containing lubricants for dry eye: a systematic review","volume":"89","author":"Lee","year":"2012","journal-title":"Optom Vis Sci"},{"issue":"4","key":"10.1016\/j.clae.2024.102154_b0215","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.clae.2010.02.003","article-title":"Tear film dynamics and lipid layer characteristics\u2014effect of age and gender","volume":"33","author":"Ma\u00efssa","year":"2010","journal-title":"Cont Lens Anterior Eye"},{"issue":"10","key":"10.1016\/j.clae.2024.102154_b0220","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1016\/j.bbamem.2016.02.020","article-title":"Tear film lipid layer: a molecular level view","volume":"1858","author":"Cwiklik","year":"2016","journal-title":"Biochimica Et Biophysica Acta (BBA)-Biomembranes"},{"key":"10.1016\/j.clae.2024.102154_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.jciso.2021.100028","article-title":"Effects of model tear proteins and topical ophthalmic formulations on evaporation inhibition and biophysical property of model tear lipid nanofilm in vitro","volume":"4","author":"Lin","year":"2021","journal-title":"JCIS Open"},{"issue":"1\u20132","key":"10.1016\/j.clae.2024.102154_b0230","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/prca.201400084","article-title":"Unraveling the molecular repertoire of tears as a source of biomarkers: beyond ocular diseases","volume":"9","author":"Pieragostino","year":"2015","journal-title":"Proteomics-Clinical Applications"},{"issue":"3","key":"10.1016\/j.clae.2024.102154_b0235","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/14789450.2017.1285703","article-title":"The power of tears: how tear proteomics research could revolutionize the clinic","volume":"14","author":"Zhou","year":"2017","journal-title":"Expert Rev Proteomics"},{"key":"10.1016\/j.clae.2024.102154_b0240","first-page":"151","article-title":"Tear fluid protein biomarkers. advances in clinical chemistry","author":"You","year":"2013","journal-title":"Elsevier"},{"issue":"4","key":"10.1016\/j.clae.2024.102154_b0245","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/cxo.12918","article-title":"Tear film, contact lenses and tear biomarkers","volume":"102","author":"Willcox","year":"2019","journal-title":"Clin Exp Optom"},{"key":"10.1016\/j.clae.2024.102154_b0250","series-title":"Quantification, and analysis of meibum and Tear lipids","author":"Collection","year":"2011"},{"key":"10.1016\/j.clae.2024.102154_b0255","first-page":"1","article-title":"Management strategies for evaporative dry eye disease and future perspective","author":"Rolando","year":"2022","journal-title":"Curr Eye Res"},{"issue":"3","key":"10.1016\/j.clae.2024.102154_b0260","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.bpj.2021.12.033","article-title":"Biophysical properties of tear film lipid layer I. Surface tension and surface rheology","volume":"121","author":"Xu","year":"2022","journal-title":"Biophys J"},{"issue":"1","key":"10.1016\/j.clae.2024.102154_b0265","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jtos.2014.06.002","article-title":"The presence and significance of polar meibum and tear lipids","volume":"13","author":"Pucker","year":"2015","journal-title":"Ocul Surf"},{"key":"10.1016\/j.clae.2024.102154_b0270","first-page":"281","article-title":"The meibomian glands and tear film lipids: structure, function, and control. lacrimal gland, Tear film, and dry eye syndromes 2","author":"Bron","year":"1998","journal-title":"Basic Science and Clinical Relevance"},{"issue":"12","key":"10.1016\/j.clae.2024.102154_b0275","doi-asserted-by":"crossref","first-page":"7417","DOI":"10.1167\/iovs.13-12916","article-title":"A comparison of patient matched meibum and tear lipidomes","volume":"54","author":"Brown","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.clae.2024.102154_b0280","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1542-0124(12)70138-6","article-title":"Meibomian gland function and the tear lipid layer","volume":"1","author":"McCulley","year":"2003","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.clae.2024.102154_b0285","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/bjophthalmol-2015-307415","article-title":"Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction","volume":"100","author":"Baudouin","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.clae.2024.102154_b0290","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.preteyeres.2004.04.003","article-title":"Changes in the tear film and ocular surface from dry eye syndrome","volume":"23","author":"Johnson","year":"2004","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.clae.2024.102154_b0295","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.2147\/OPTH.S377960","article-title":"Propylene glycol and hydroxypropyl Guar nanoemulsion-safe and effective lubricant eye drops in the Management of dry eye Disease","author":"Srinivasan","year":"2022","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.clae.2024.102154_b0300","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1089\/jop.2018.0031","article-title":"Preclinical evaluation of a new hydroxypropyl-guar phospholipid nanoemulsion-based artificial tear formulation in models of corneal epithelium","volume":"35","author":"Rangarajan","year":"2019","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.clae.2024.102154_b0305","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.2147\/OPTH.S263362","article-title":"Symptom relief following a single dose of propylene glycol-hydroxypropyl guar nanoemulsion in patients with dry eye disease: a phase IV, multicenter trial","author":"Silverstein","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.clae.2024.102154_b0310","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.2147\/OPTH.S261318","article-title":"Efficacy and safety of phospholipid nanoemulsion-based ocular lubricant for the management of various subtypes of dry eye disease: a phase IV, multicenter trial","author":"Yeu","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.clae.2024.102154_b0315","article-title":"The TFOS international workshop on contact lens discomfort: executive summary","volume":"54(11):TFOS7-TFOS13","author":"Nichols","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.clae.2024.102154_b0320","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.clae.2019.10.141","article-title":"Evaluation of systane complete for the treatment of contact lens discomfort","volume":"43","author":"Pucker","year":"2020","journal-title":"Cont Lens Anterior Eye"},{"issue":"4","key":"10.1016\/j.clae.2024.102154_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2020.12.004","article-title":"Application of systane complete for the treatment of contact lens discomfort","volume":"44","author":"Pucker","year":"2021","journal-title":"Cont Lens Anterior Eye"},{"issue":"2","key":"10.1016\/j.clae.2024.102154_b0330","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/OPX.0000000000000996","article-title":"Lipid supplements and clinical aspects of tear film in habitual lens wearers","volume":"94","author":"Rohit","year":"2017","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.clae.2024.102154_b0335","article-title":"Lipid Supplements & Biochemical Aspects of Tear film in habitual lens Wearers","volume":"57(12):6192-","author":"Rohit","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"10.1016\/j.clae.2024.102154_b0340","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/OPX.0000000000000947","article-title":"Effects of lipid supplements on tear biochemistry in contact lens wearers","volume":"93","author":"Rohit","year":"2016","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.clae.2024.102154_b0345","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2147\/OPTH.S75297","article-title":"An evaluation of retaine\u2122 ophthalmic emulsion in the management of tear film stability and ocular surface staining in patients diagnosed with dry eye","volume":"9","author":"Ousler","year":"2015","journal-title":"Clinical Ophthalmology (auckland, NZ)"},{"key":"10.1016\/j.clae.2024.102154_b0350","article-title":"Assessment of quality of life and symptom reduction in dry eye subjects using retaine\u2122 ophthalmic emulsion","volume":"56(7):4483-","author":"Watson","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.clae.2024.102154_b0355","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/01.opx.0000171818.01353.8c","article-title":"The effect of two novel lubricant eye drops on tear film lipid layer thickness in subjects with dry eye symptoms","volume":"82","author":"Korb","year":"2005","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.clae.2024.102154_b0360","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.2147\/OPTH.S120158","article-title":"Tear lipid layer thickness with eye drops in meibomian gland dysfunction","author":"Fogt","year":"2016","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"10.1016\/j.clae.2024.102154_b0365","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000512635","article-title":"Evaluation of Carboxymethylcellulose sodium plus glycerin (optive\u00ae) in Ocular discomfort after anti-Vascular endothelial growth factor intravitreal injection therapy: a prospective study","volume":"244","author":"Karcenty","year":"2021","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.clae.2024.102154_b0370","first-page":"97","article-title":"Short-term efficacy of two lipidic eyedrops in the treatment of evaporative dry eye","volume":"2","author":"Fogagnolo","year":"2016","journal-title":"Ital Rev Ophthalmol"},{"key":"10.1016\/j.clae.2024.102154_b0375","article-title":"Can OTC artificial tears ophthalmic solutions stabilize tear film? an in vitro study","volume":"59(9):3825-","author":"Lin","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.clae.2024.102154_b0380","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jtos.2019.11.004","article-title":"An artificial tear containing flaxseed oil for treating dry eye disease: a randomized controlled trial","volume":"18","author":"Downie","year":"2020","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.clae.2024.102154_b0385","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ophtha.2016.09.023","article-title":"A randomized, double-masked, placebo-controlled clinical trial of two forms of omega-3 supplements for treating dry eye disease","volume":"124","author":"Deinema","year":"2017","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.clae.2024.102154_b0390","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.1167\/iovs.13-12081","article-title":"Efficacy of osmoprotectants on prevention and treatment of murine dry eye","volume":"54","author":"Chen","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clae.2024.102154_b0395","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.2147\/OPTH.S228261","article-title":"Changes in tear lipid layer thickness and symptoms following the use of artificial tears with and without omega-3 fatty acids: a randomized, double-masked, crossover study","volume":"13","author":"Fogt","year":"2019","journal-title":"Clinical Ophthalmology (auckland, NZ)"},{"issue":"9","key":"10.1016\/j.clae.2024.102154_b0400","first-page":"3814","article-title":"Changes in tear lipid layer thickness with Omega-3 eye drop","volume":"59","author":"Fogt","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.clae.2024.102154_b0405","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1097\/00140068-200301001-00026","article-title":"Eyelid disorders: the meibomian gland, blepharitis, and contact lenses","volume":"29","author":"McCulley","year":"2003","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.clae.2024.102154_b0410","first-page":"974","article-title":"Comparative study of treatment of the dry eye syndrome due to disturbances of the tear film lipid layer with lipid-containing tear substitutes efficacy of lipid-containing tear substitutes","volume":"223","author":"Dieter","year":"2006","journal-title":"Klin Monatsbl Augenheilkd"},{"issue":"5","key":"10.1016\/j.clae.2024.102154_b0415","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.clae.2012.05.003","article-title":"Effect of three different liposomal eye sprays on ocular comfort and tear film","volume":"35","author":"Pult","year":"2012","journal-title":"Cont Lens Anterior Eye"},{"issue":"1","key":"10.1016\/j.clae.2024.102154_b0420","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clae.2017.07.007","article-title":"Can the optimum artificial tear treatment for dry eye disease be predicted from presenting signs and symptoms?","volume":"41","author":"Essa","year":"2018","journal-title":"Cont Lens Anterior Eye"},{"issue":"10","key":"10.1016\/j.clae.2024.102154_b0425","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1055\/s-2004-813715","article-title":"A new therapy concept for the treatment of dry eye\u2013the usefulness of phospholipid liposomes","volume":"221","author":"Lee","year":"2004","journal-title":"Klin Monatsbl Augenheilkd"},{"issue":"2","key":"10.1016\/j.clae.2024.102154_b0430","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.clae.2009.12.007","article-title":"Effect of a liposomal spray on the pre-ocular tear film","volume":"33","author":"Craig","year":"2010","journal-title":"Cont Lens Anterior Eye"},{"issue":"8","key":"10.1016\/j.clae.2024.102154_b0435","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/ICL.0000000000000788","article-title":"Effect of eye spray phospholipid concentration on the tear film and ocular comfort","volume":"47","author":"Pult","year":"2021","journal-title":"Eye Contact Lens"},{"issue":"5\u20136","key":"10.1016\/j.clae.2024.102154_b0440","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.drudis.2012.10.005","article-title":"Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers","volume":"18","author":"Gan","year":"2013","journal-title":"Drug Discov Today"},{"issue":"2","key":"10.1016\/j.clae.2024.102154_b0445","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/ICO.0000000000000660","article-title":"Efficacy and safety of carbomer-based lipid-containing artificial tear formulations in patients with dry eye syndrome","volume":"35","author":"Chung","year":"2016","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.clae.2024.102154_b0450","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1194\/jlr.M044826","article-title":"Extensive characterization of human tear fluid collected using different techniques unravels the presence of novel lipid amphiphiles","volume":"55","author":"Lam","year":"2014","journal-title":"J Lipid Res"},{"issue":"9","key":"10.1016\/j.clae.2024.102154_b0455","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1080\/10408444.2019.1694862","article-title":"Mineral oil in food, cosmetic products, and in products regulated by other legislations","volume":"49","author":"Pirow","year":"2019","journal-title":"Crit Rev Toxicol"},{"issue":"12","key":"10.1016\/j.clae.2024.102154_b0460","doi-asserted-by":"crossref","first-page":"6220","DOI":"10.1167\/iovs.10-5687","article-title":"Shotgun lipidomic analysis of human meibomian gland secretions with electrospray ionization tandem mass spectrometry","volume":"51","author":"Chen","year":"2010","journal-title":"Invest Ophthalmol vis Sci"},{"issue":"6","key":"10.1016\/j.clae.2024.102154_b0465","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1167\/iovs.16-19131","article-title":"omega-3 Tear film lipids Correlate with clinical measures of dry eye","volume":"57","author":"Walter","year":"2016","journal-title":"Invest Ophthalmol vis Sci"}],"container-title":["Contact Lens and Anterior Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367048424000468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367048424000468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T18:58:44Z","timestamp":1718477924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1367048424000468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":93,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1367048424000468"],"URL":"https:\/\/doi.org\/10.1016\/j.clae.2024.102154","relation":{},"ISSN":["1367-0484"],"issn-type":[{"value":"1367-0484","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid-based eye drop formulations for the management of evaporative dry eyes","name":"articletitle","label":"Article Title"},{"value":"Contact Lens and Anterior Eye","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clae.2024.102154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of British Contact Lens Association.","name":"copyright","label":"Copyright"}],"article-number":"102154"}}